Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
- Matthias D. Hofer
- , Mark A. Rubin
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.